178 related articles for article (PubMed ID: 20852150)
1. Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression.
Mordasky Markell L; Pérez-Lorenzo R; Masiuk KE; Kennett MJ; Glick AB
Carcinogenesis; 2010 Dec; 31(12):2127-35. PubMed ID: 20852150
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic inhibition of ALK5 causes selective induction of terminal differentiation in mouse keratinocytes expressing oncogenic HRAS.
Markell LM; Masiuk KE; Blazanin N; Glick AB
Mol Cancer Res; 2011 Jun; 9(6):746-56. PubMed ID: 21521744
[TBL] [Abstract][Full Text] [Related]
3. Tumor-promoting role of TGFβ1 signaling in ultraviolet B-induced skin carcinogenesis is associated with cutaneous inflammation and lymph node migration of dermal dendritic cells.
Ravindran A; Mohammed J; Gunderson AJ; Cui X; Glick AB
Carcinogenesis; 2014 Apr; 35(4):959-66. PubMed ID: 24363069
[TBL] [Abstract][Full Text] [Related]
4. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
Go C; Li P; Wang XJ
Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis.
Pérez-Lorenzo R; Markell LM; Hogan KA; Yuspa SH; Glick AB
Carcinogenesis; 2010 Jun; 31(6):1116-23. PubMed ID: 20172950
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
7. SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism.
Xiao YQ; Liu K; Shen JF; Xu GT; Ye W
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1698-706. PubMed ID: 19098325
[TBL] [Abstract][Full Text] [Related]
8. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
[TBL] [Abstract][Full Text] [Related]
9. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB
Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
[TBL] [Abstract][Full Text] [Related]
11. Role of ALK5/Smad2/3 and MEK1/ERK Signaling in Transforming Growth Factor Beta 1-modulated Growth, Collagen Turnover, and Differentiation of Stem Cells from Apical Papilla of Human Tooth.
Chang HH; Chang MC; Wu IH; Huang GF; Huang WL; Wang YL; Lee SY; Yeh CY; Guo MK; Chan CP; Hsien HC; Jeng JH
J Endod; 2015 Aug; 41(8):1272-80. PubMed ID: 26001858
[TBL] [Abstract][Full Text] [Related]
12. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.
Go C; He W; Zhong L; Li P; Huang J; Brinkley BR; Wang XJ
Oncogene; 2000 Jul; 19(32):3623-31. PubMed ID: 10951568
[TBL] [Abstract][Full Text] [Related]
13. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
Liu IM; Schilling SH; Knouse KA; Choy L; Derynck R; Wang XF
EMBO J; 2009 Jan; 28(2):88-98. PubMed ID: 19096363
[TBL] [Abstract][Full Text] [Related]
14. Activin receptor-like kinase 5 inhibition reverses impairment of endothelial cell viability by endogenous islet mesenchymal stromal cells.
Clarkin CE; King AJ; Dhadda P; Chagastelles P; Nardi N; Wheeler-Jones CP; Jones PM
Stem Cells; 2013 Mar; 31(3):547-59. PubMed ID: 23255220
[TBL] [Abstract][Full Text] [Related]
15. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
16. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis.
Fan Q; He M; Sheng T; Zhang X; Sinha M; Luxon B; Zhao X; Xie J
J Biol Chem; 2010 Nov; 285(47):36570-6. PubMed ID: 20858897
[TBL] [Abstract][Full Text] [Related]
17. Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis.
Badalucco S; Di Buduo CA; Campanelli R; Pallotta I; Catarsi P; Rosti V; Kaplan DL; Barosi G; Massa M; Balduini A
Haematologica; 2013 Apr; 98(4):514-7. PubMed ID: 23403314
[TBL] [Abstract][Full Text] [Related]
18. Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycans.
Osman N; Grande-Allen KJ; Ballinger ML; Getachew R; Marasco S; O'Brien KD; Little PJ
Cardiovasc Pathol; 2013; 22(2):146-55. PubMed ID: 22999704
[TBL] [Abstract][Full Text] [Related]
19. Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.
Connolly EC; Saunier EF; Quigley D; Luu MT; De Sapio A; Hann B; Yingling JM; Akhurst RJ
Cancer Res; 2011 Mar; 71(6):2339-49. PubMed ID: 21282335
[TBL] [Abstract][Full Text] [Related]
20. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
